Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

NCT07127978 is registered in ClinicalTrials.gov with ITF Therapeutics LLC as lead sponsor.

NCT NCT07127978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07127978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
Lead sponsor
ITF Therapeutics LLC
Phase
Observational
Overall status
Recruiting
Start date
October 23, 2025
Completion date
July 30, 2030
Enrollment
300 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

duchene muscular dystrophy